Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(56), p. 3438-3440, 2012
DOI: 10.1128/aac.00135-12
Links
- ORCID
- American Society for Microbiology | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Successful Long-Term Treatment of Cerebral Nocardiosis with Unexpectedly Low Doses of Linezolid in an Immunocompromised Patient Receiving Complex Polytherapy
Journal article published in 2012 by
Federico Pea 
,
Piergiorgio Cojutti,
Alberto Pagotto,
Francesco Cristini,
Mario Furlanut,
Pierluigi Viale
,
Piergiorgio Cojutti,
Alberto Pagotto,
Francesco Cristini,
Mario Furlanut,
Pierluigi Viale
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
ABSTRACT Cerebral nocardiosis is a severe infection that carries the highest mortality rate among all bacterial cerebral abscesses. We report on a case in an immunocompromised patient which was successfully treated with unexpectedly low doses of linezolid. Therapeutic drug monitoring was very helpful in highlighting issues of poor compliance and of drug-drug interactions.